179 POSTER Phase I study of the novel anti-cancer drug PM00104 as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors or lymphoma
J.C. Soria, R. Plummer, A. Soto, C. Massard, H. Calvert, R. Prados, E. Angevin, C. Jones, B. de las HerasVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72111-6
File:
PDF, 62 KB
english, 2008